Unlock Strategic Intelligence with Fundz

Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.

Via Scientific Raises $5M In Seed Funding To Accelerate The Pace Of Life Sciences Discovery

01/09/24, 4:02 PM

Location

cambridge

Money raised

$5 million

Industry

biotechnology

Round Type

seed

Investors

Janet Kosloff, Founder, And Former Ceo Of In Crowd, Inc., Rob Hickey, Former Evp At Data Robot, Melissa J. Moore, Innospark Ventures, G20 Ventures

Via Scientific, Inc., developer of Via Foundry, the multi-omics platform that enables pharmaceutical companies, bio-techs and academic researchers to go faster in discovering novel biological insights, today announced the closing of $5m in funding led by G20 Ventures and Innospark Ventures. The syndicate also includes notable Life Science and AI Angel investors including Melissa J. Moore, former CSO of Moderna; Rob Hickey, Former EVP at DataRobot; and Janet Kosloff, Founder, and former CEO of InCrowd, Inc.

🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.

Company Info

Company

Via Scientific

Location

cambridge, maryland, united states

Additional Info

Via Scientific’s Foundry platform radically simplifies enterprise scale multi-omics and analytics, freeing scientists, computational biologists and bioinformaticians to focus on their science rather than writing code and managing compute infrastructure.

Track Every New Funding Round — Before Anyone Else

This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.

Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.

Related people

Trends

	Raised	Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage.
biotechnology	$9.4 B	-20.8%